Multigene panel testing for hereditary breast/ovarian cancer risk assessment

(The JAMA Network Journals) Multigene testing of women negative for BRCA1 and BRCA2 found some of them harbored other harmful genetic mutations, most commonly moderate-risk breast and ovarian cancer genes and Lynch syndrome genes, which increase ovarian cancer risk, according to an article published online by JAMA Oncology.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news